Business Wire

SYNAPS Dx Observes September as World Alzheimer’s Month and Healthy Aging Month: Celebrates Researchers, Providers and Patients

ROCKLAND, Md.--(BUSINESS WIRE)--SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer’s disease (AD), recognizes ...
Business Wire

SYNAPS Dx Releases Autopsy-Confirmed Results for DISCERN™ Alzheimer’s Test and Physicians’ Assessment of Clinical Utility of DISCERN at BRAINWeek 2023

ROCKVILLE, Md.--(BUSINESS WIRE)--SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer’s disease (AD), recently ...
PharmiWeb

SYNAPS Dx Opens High-Tech Laboratory Supporting Research & Commercialization of DISCERN, Highly Accurate, Minimally Invasive Alzheimer’s Disease Diagnostic Test

ROCKVILLE, Md.--(BUSINESS WIRE)--SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer’s disease (AD), is pleased to ...
Yahoo Finance

SYNAPS Dx Observes November as National Alzheimer’s Disease Awareness Month and National Family Caregivers Month: Honoring Those Impacted by Alzheimer’s

ROCKVILLE, Md., November 01, 2023--(BUSINESS WIRE)--SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer’s disease ...